ASPEN statement on parenteral nutrition standardization.
In response to questions regarding use of standardized parenteral nutrition (PN) formulations, the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) developed a Task Force to address some of these issues. A.S.P.E.N. envisions standardized PN as a broader issue rather than simply using a standardized, commercially available PN product. A standardized process for PN must be explored in order to improve patient safety and clinical appropriateness, and to maximize resource efficiency. A standardized process may include use of standardized PN formulations (including standardized, commercial PN products) but also includes aspects of ordering, labeling, screening, compounding, and administration of PN. A safe PN system must exist which minimizes procedural incidents and maximizes the ability to meet individual patient requirements. Using clinicians with nutrition support therapy expertise will contribute to that safe PN system. The purpose of this statement is to present the published literature associated with standardized PN formulations, to provide recommendations, and to identify areas in need of future research.
Kochevar
Marty
M
Guenter
Peggi
P
Holcombe
Beverly
B
Malone
Ainsley
A
Mirtallo
Jay
J
D016303:Clinical Pharmacy Information Systems; D003257:Consumer Product Safety; D004046:Dietetics / Q000592:standards*; D004339:Drug Compounding / Q000592:standards; D005526:Food, Formulated / Q000592:standards*; D006801:Humans; D050316:Medical Order Entry Systems; D009751:Nutritional Requirements; D010288:Parenteral Nutrition / Q000592:standards*; D010348:Patient Care Team; D012952:Societies; D014481:United States